坦索罗辛暴露患者白内障手术并发症风险演变:基于人群研究
该研究纳入2003至2013年加拿大安大略省66岁及以上接受白内障手术的男性患者,利用关联健康数据库分析坦索罗辛暴露与非暴露患者手术不良事件风险随时间的变化。结果显示两组患者手术不良事件风险均逐年下降,坦索罗辛暴露者比值比为每年0.95(95%CI 0.91-0.99),非近期暴露者为每年0.96(95%CI 0.95-0.98)。坦索罗辛仍是白内障手术不良事件的重要危险因素。
要点
- 坦索罗辛暴露患者白内障手术不良事件风险逐年下降,OR为每年0.95(95%CI 0.91-0.99)。
- 非近期坦索罗辛暴露患者手术不良事件风险亦逐年下降,OR为每年0.96(95%CI 0.95-0.98)。
- 坦索罗辛仍是白内障手术不良事件的重要危险因素,需持续推广降低风险的手术方法。
核心结论
- 2003至2013年间,坦索罗辛暴露与非暴露患者白内障手术并发症风险均下降,但坦索罗辛仍是重要危险因素。
主要发现
- 坦索罗辛暴露患者手术不良事件风险随时间下降,比值比为每年0.95(95%CI 0.91-0.99)。
- 非近期坦索罗辛暴露患者手术不良事件风险也随时间下降,比值比为每年0.96(95%CI 0.95-0.98)。
- 风险下降趋势在坦索罗辛暴露患者各年龄层中均观察到。
关键数值与推荐
- 评估的四项白内障手术不良事件为:后囊膜破裂、晶状体碎片坠入玻璃体、视网膜脱离和疑似眼内炎。
临床怎么用
- 临床应继续关注坦索罗辛暴露患者的白内障手术风险,并采用可降低风险的手术技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Tamsulosin is associated with intraoperative floppy iris syndrome (IFIS), an important risk factor for complications during cataract surgery. Significant efforts have been made to increase awareness of the risks associated with tamsulosin, and educational initiatives have fostered the uptake of technical adjustments to decrease adverse event rates among tamsulosin-exposed patients. However, the effectiveness of these efforts at the population level has not been studied. DESIGN: Population-based study to evaluate cataract surgical adverse event rates over time among patients exposed to tamsulosin and those not exposed to this drug. PARTICIPANTS: All male patients 66 years of age and older undergoing cataract surgery in Ontario, Canada, between January 1, 2003, and December 31, 2013, were included in the study. METHODS: Linked healthcare databases were used to study the evolution in the risk of cataract surgical adverse events over time among tamsulosin-exposed and non-tamsulosin-exposed patients adjusting for patient-, surgeon-, and institution-level covariates. The study timeframe incorporated periods before and after the first reports of tamsulosin-associated IFIS. MAIN OUTCOME MEASURES: Four important cataract surgical adverse events were evaluated: posterior capsule rupture, dropped lens fragments, retinal detachment, and suspected endophthalmitis. RESULTS: Among patients exposed to tamsulosin, the risk of surgical adverse events decreased over time (odds ratio, 0.95 per year; 95% confidence interval, 0.91-0.99 per year). This trend was observed across patient age strata. Among patients not recently exposed to tamsulosin, the risk of surgical adverse events also decreased over time (odds ratio, 0.96 per year; 95% confidence interval, 0.95-0.98 per year). CONCLUSIONS: The risk of cataract surgical complications among both tamsulosin-exposed and non-tamsulosin-exposed patients declined between 2003 and 2013. Tamsulosin remains an important risk factor for cataract surgical adverse events, and ongoing efforts will be needed to develop and disseminate surgical approaches that mitigate the risks posed by tamsulosin.
引用
- Campbell RJ, El-Defrawy SR, Gill SS, et al. Evolution in the Risk of Cataract Surgical Complications among Patients Exposed to Tamsulosin: A Population-Based Study. Ophthalmology. 2019. PMID: 30648549. doi:10.1016/j.ophtha.2018.11.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。